Drug search by name

Trabectedin Intravenous and Neutropenic sepsis

Result of checking the interaction of drug Trabectedin Intravenous and disease Neutropenic sepsis for safety when used together.

Check result:

Trabectedin Intravenous <> Neutropenic sepsis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of trabectedin has been associated with neutropenic sepsis, including fatal cases. It is recommended to monitor neutrophil count before each dose of trabectedin and periodically during treatment. Withhold treatment if the neutrophil count is less than 1,500 cells/microliter on the treatment day and permanently reduce the dose for life-threatening or prolonged, severe neutropenia in the preceding cycle. Therapy with trabectedin should be administered cautiously in patients predisposed to neutropenia. Patients should be warned to report any febrile illness.

Trabectedin Intravenous

Generic Name: trabectedin

Brand Name: Yondelis

Synonyms: Trabectedin

What is Trabectedin Intravenous?